vTv Therapeutics logo

vTv Therapeutics

VTVT | NASDAQ
Chart Builder DCF Calculator
$17.69
-$2.00 (-10.16%)
At close: Nov 16, 2026, 4:00 PM ET
$17.69
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-10.16%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #715/1021 (Top 70%)

Key Statistics

Market Data

Market Cap $69.95M
1D Range
17.28 19.41
52W Range
17.28 42.72

Valuation (TTM)

PE -
PB 1.00
EV/EBITDA -1.83

Valuation (NTM)

Forward PE N/A
Forward PEG -11.19
Price Target $42.00
Loading financial charts...

Profile

vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipel...

Sector Healthcare
Industry Biotechnology
Employees 26
IPO Date Jul 30, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$42.00
Upside
+137.42%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.